No data for homocysteine screening

A Canadian physician recommends screening for homocysteine. There is no data to support this recommendation:

While screening for hyperhomocysteinemia itself is not difficult, a benefit from lowering the homocysteine concentration on cardiovascular and venous thromboembolic disease remains unproven. Thus, even if we identify patients with an elevated homocysteine concentration it is not clear that acting on this information is of benefit.

Related posts:

1. When screening isn’t supported by evidence
2. Should heart disease screening tests be covered by insurance?
3. PSA screening
4. The data argues against an annual physical, but is it still needed?
5. Should prostate cancer screening stop after the age of 75?
6. An upper age limit for screening mammography?
7. MRI for breast cancer screening

  Follow on Twitter   Subscribe

Tagged as: patient